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Abstract The synthesis and nuclease activity of a new
bifunctional heterodinuclear platinum–copper complex are
reported. The design of this ditopic coordination compound is
based on the specific mode of action of each component,
namely, cisplatin and Cu(3-Clip-Phen), where 3-Clip-Phen
is 1-(1,10-phenanthrolin-3-yloxy)-3-(1,10-phenanthrolin-8-
yloxy)propan-2-amine. Cisplatin is not only able to direct the
Cu(3-Clip-Phen) part to the GG or AG site, but also acts as a
kinetically inert DNA anchor. The nuclease activity of this
complex has been investigated on supercoiled DNA. The di-
nuclear compound is not only more active than Cu(3-Clip-
Phen), but is also capable of inducing direct double-strand
breaks. The sequence selectivity of the mononuclear platinum
complex has been investigated by primer extension experi-
ments, which reveal that its interaction with DNA occurs at the
same sites as for cisplatin. The Taq polymerase recognizes the
resulting DNA damage as different from that for unmodified
cisplatin. The sequence-selective cleavage has been investi-
gated by high-resolution gel electrophoresis on a 36-bp DNA
fragment. Sequence-selective cleavages are observed in the
close proximity of the platinum sites for the strand exhibiting
the preferential platinum binding sites. The platinum moiety
also coordinates to the other DNA strand, most likely leading
only to mono guanine or adenine adducts.
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Abbreviations
3-Clip-
Phen
1-(1,10-Phenanthrolin-3-yloxy)-3-(1,10-
phenanthrolin-8-yloxy)propan-2-amine
DCM Dichloromethane
DMF Dimethylformamide
DMSO Dimethyl sulfoxide
ESI Electrospray ionization
HEPES 4-(2-Hydroxyethyl)-1-
piperazineethanesulfonic acid
MS Mass spectrometry
ODN Oligonucleotide
TBE 2-Amino-2-(hydroxymethyl)propane-1,3-diol
borate edta
Tris 2-Amino-2-(hydroxymethyl)propane-1,3-diol
Introduction
DNA is a target for numerous antitumor drugs [1, 2].
Reversible or irreversible modifications of the nucleic acids
can lead to disruption of the transcription and/or replica-
tion, initiating ultimately the death of cancer cells.
Cisplatin [3] and bleomycin are among these efficient
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anticancer drugs [4]. The mechanism of action is different
for both drug substances; cisplatin primarily induces dis-
tortions upon binding to DNA, whereas bleomycin is able
to generate DNA strand scissions.
Since the discovery of bleomycin [5], numerous metal
complexes have been synthesized that are able to produce
DNA cleavage. Typical examples are iron(II)–edta com-
plexes, manganese(III)–porphyrin and Cu, Co, Ru and Rh
complexes with phenanthroline [6–9]. For instance,
Cu(phen)2
+ in the presence of dihydrogen peroxide effi-
ciently cleaves double-stranded DNA through the oxidative
attack on deoxyribose units from the minor groove [10, 11].
The consequent DNA-cleavage products include 50-mono-
phosphate and 30-monophosphate ester termini, free bases,
5-methylene furanone, and a small amount of 30-phospho-
glycolate [12–14]. Dihydrogen peroxide can be generated by
Cu(phen)2
2+ in close proximity to the DNA strands, in the
presence of a reductant and molecular oxygen [15]. The
nuclease activity of Cu(phen)2 has been enhanced with the
synthesis of 1-(1,10-phenanthrolin-3-yloxy)-3-(1,10-phen-
anthrolin-8-yloxy)propan-2-amine (3-Clip-Phen, 4) based
on the covalent linkage of two phenanthroline units through
their 3-position, leading to an increase of 60 times compared
with the nuclease activity of Cu(phen)2 itself [15]. However,
similarly to Cu(phen)2, the copper complexes of 3-Clip-
Phen have no sequence selectivity, and cleave the DNA in a
single-stranded fashion. The amine group of 3-Clip-Phen
has been functionalized with different groups, such as a
distamycin analog or various DNA intercalators [16, 17].
Thus, the resulting complexes show enhanced cleaving
activities, and the complexes with the distamycin analog
exhibit excellent targeting properties toward AT boxes [18].
Recently, it has been shown that Cu(3-Clip-Phen) (3)
attached to a cisplatin motif is able to perform direct
double-strand cuts, thanks to the DNA-anchoring platinum
moiety [19]. Platinum complexes have received consider-
able attention since the discovery of the antiproliferate
activity of cisplatin in 1969 [20]. It is generally accepted
that the distortion of DNA generated upon binding of cis-
platin is largely responsible for its antitumor properties [3].
Subsequent drug activation via intracellular aquation
reactions results in a variety of stable bifunctional DNA–
platinum(II) adducts. 1,2-Intrastrand cross-links between
two adjacent guanine bases d(GG) or between an adenine
and a guanine residue d(AG) are primarily formed. The
platinum center of complexes with a cis motif preferen-
tially coordinates to the N7 position of both adenine and
guanine in the major groove of DNA [21–24].
In the present paper, the preparation of a bifunctional
complex [CuPt[N1-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-
phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-diamine]Cl4,
2] containing both a cis-bis(amine)Pt(II) moiety and a
nuclease active 3-Clip-Phen group is reported (Fig. 1). The
bridge connecting the platinum and copper moieties is very
short and therefore rigid in contrast to that in the previous
report, where the complexes had flexible linkers in order to
have a major–minor groove interaction [19]. The platinum
and the 3-Clip-Phen adjacent parts are now separated by a
short linker. Consequently, in this case either the platinum
species will not interact with its preferential site (the major
groove) or the 3-Clip-Phen moiety will not interact with its
preferential site (the minor groove). The platinum com-
ponent plays two roles: (1) it acts as a DNA anchor, thus
allowing the Cu(3-Clip-Phen) moiety to perform cleavages
in the close proximity of the Pt–DNA adducts, and (2) it
induces a sequence-selective binding of the heterodinuclear
complex. Accordingly, the achievement of double-strand
DNA breaks is potentially increased, because the single-
strand cuts are in the close proximity of the platinum
adduct and sequence-selective cleavage may be expected.
In the present study, the binding property of the plati-
num moiety and the cleavage selectivity and activity of this
novel heterodinuclear complex 2 were investigated by
agarose gel electrophoresis and high-resolution analysis
with a 36-bp DNA fragment (Fig. 2). The results obtained
are compared with those achieved with cisplatin and the
Cu(3-Clip-Phen) complex.
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Fig. 1 Complexes 1–3
Fig. 2 Nucleobase sequences of oligonucleotide I (ODN I), oligonu-
cleotide II (ODN II) and the primer used for the binding experiments.
The preferential binding sites of cisplatin are indicated by arrowheads
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Materials and methods
Preparation of Pt[N1-(3-(1,10-phenanthrolin-3-yloxy)-
1-(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-
diamine]Cl2 and 2
All reagents and solvents were commercially available and
used without further purification. Cu(3-Clip-Phen) (3) was
prepared as previously described [15]. The 1H NMR
chemical shifts of standard solvent molecules have been
omitted in all redrawn spectra for clarity.
2-(2-(3-(1,10-Phenanthrolin-3-yloxy)-1-(1,10-phena-
nthrolin-8-yloxy)propan-2-ylamino)ethyl)isoindoline-
1,3-dione
3-Clip-Phen (4) (100 mg, 0.22 mmol) was dissolved in
5 mL of dimethylformamide (DMF). One equivalent of N-
(2-bromoethyl)phthalimide (5) (56.7 mg, 0.22 mmol) and
1 equiv of N-ethyldiisopropylamine (38 lL, 0.22 mmol)
were added to 4. The reaction mixture was heated to 100 C
for 2 days. After the mixture had cooled to room tempera-
ture, 10 mL of dichloromethane (DCM) was added, and the
organic phase was washed three times with 10 mL of dis-
tilled water. After being dried over Na2SO4 and evaporation
under reduced pressure, the resulting crude product was
purified by column chromatography (SiO2, DCM, MeOH,
NH4OH, 95:5:0.5), to yield 2-(2-(3-(1,10-phenanthrolin-
3-yloxy)-1-(1,10-phenanthrolin-8-yloxy)propan-2-ylamino)
ethyl)isoindoline-1,3-dione (6) as an off-white powder
(yield 34%). 1H NMR (DCCl3, 300 MHz) d 9.05 (dd, 2H,
J = 4.32, 1.67 Hz), 8.81 (d, 2H, J = 2.83 Hz), 8.10 (dd,
2H, J = 8.07, 1.62 Hz), 7.72 (dd, 2H, J = 5.43, 3.05 Hz),
7.67 (d, 2H, J = 8.88 Hz), 7.62 (d, 2H J = 8.86 Hz), 7.54
(dd, 2H, J = 6.09, 4.74 Hz), 7.48 (m, 4H), 4.27 (d, 4H,
J = 5.18 Hz), 3.84 (t, 2H, J = 6.06 Hz), 3.54 (m, 1H), 3.13
(t, 2H, J = 6.12 Hz) ppm. 13C NMR (DCCl3, 75 MHz) d
168.4, 153.7, 150.1, 146.0, 142.4, 140.3, 135.73, 133.8,
132.0, 129.3, 127.1, 125.9, 123.0, 122.0, 114.9, 67.3, 55.6,
45.4, 37.8 ppm. Low-resolution mass spectrometry (MS)
(electrospray ionization, ESI, more than 0) m/z 621.00
[(M + H)+; calcd for C37H29N6O4
+: 621.66], 642.94
[(M + Na)+; calcd for C37H28N6O4Na
+: 643.65] Anal.
calcd for C37H28N6O41.6 H2O: C, 68.42; H, 4.84; N, 12.94.
Found: C, 68.34; H, 4.86; N, 13.21.
N1-(3-(1,10-Phenanthrolin-3-yloxy)-1-(1,10-phenan-
throlin-8-yloxy)propan-2-yl)ethane-1,2-diamine
Two equivalents of hydrazine (15.6 lL, 0.32 mmol) were
added to a solution of 6 (100 mg, 0.16 mmol) in 5 mL of
pure ethanol. The mixture was refluxed overnight. The
ethanol was evaporated under reduced pressure, and the
crude product was purified by column chromatography
(SiO2, DCM, MeOH, NH4OH, 90:10:1) to give N
1-
(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-phenanthrolin-8-
yloxy)propan-2-yl)ethane-1,2-diamine (7) as a light-brown
powder (yield 73%). 1H NMR (MeOD-d3, 300 MHz) d
9.00 (dd, 2H, J = 4.41, 1.63 Hz), 8.84 (d, 2H,
J = 2.84 Hz), 8.34 (dd, 2H, J = 8.10, 1.67 Hz), 7.90 (d,
2H, J = 2.86 Hz), 7.83 (m, 4H), 7.65 (dd, 2H, J = 8.10,
3.26 Hz), 4.51 (d, 4H, J = 4.47 Hz), 3.58 (m, 1H), 3.07 (t,
2H, J = 5.64 Hz), 2.97 (t, 2H, J = 5.23) ppm. 13C NMR
(MeOD-d3, 75 MHz) d 155.6, 150.6, 146.3, 143.0, 140.5,
137.6, 131.0, 128.7, 128.2, 127.4, 123.5, 116.7, 69.1, 57.5,
41.9 ppm. Low-resolution MS (ESI [ 0) m/z 490.98
[(M + H)+; calcd for C29H27N6O2
+: 491.56] Anal. calcd
for C29H26N6O21.9 CH2Cl2: C, 56.93; H, 4.61; N, 12.89.
Found: C, 56.79; H, 5.13; N, 13.23.
Pt[N1-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-
phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-
diamine]Cl2
To a solution of 7 (70.4 mg, 0.14 mmol) in 6.5 mL of DMF
was added a solution of 0.8 equiv of K2PtCl4 (47.69 mg,
0.11 mmol) in 3.25 mL of de-ionized H2O. The reaction
mixture was stirred for 6 h at room temperature. The off-
white precipitate was filtered off and washed with 30 mL of
deionized water, 30 mL of MeOH and 20 mL of diethyl
ether to give Pt[N1-(3-(1,10-phenanthrolin-3-yloxy)-1-
(1,10-phenanthrolin-8-yloxy)propan-2-yl)ethane-1,2-dia-
mine]Cl2 (1) as an off-white powder (yield 42%).
1H NMR
(DMSO-d6, where DMSO is dimethyl sulfoxide, 300 MHz)
d 9.04 (d, 2H, J = 2.77 Hz), 8.88 (d, 2H, J = 2.45 Hz),
8.45 (d, 2H, J = 8.00 Hz), 8.05 (br, 2H), 7.95 (m, 4H), 7.70
(dd, 2H, J = 7.99, 4.35 Hz), 4.49 (br, 4H), 4.07 (br, 5H)
ppm. 195Pt NMR (DMSO-d6) d -2,317 (complex), -3,292
(complex with one DMSO coordinated) ppm. IR (neat):
m = 3,049 (br); 1,591 (s); 1,506 (s); 1,424 (s); 1,236 (s);
1,198 (s); 1,102 (s); 1,018 (s); 876 (s), 834 (s), 728 (s), 332
(s), 325 (s) cm-1. Anal. calcd for C29H26Cl2N6O2PtDMF:
C, 46.33; H, 4.01; N, 11.82 Found: C, 47.54; H, 4.43; N;
11.70; the deviation in calculated percentage C is ascribed
to traces of solvent other than DMF.
CuPt[N1-(3-(1,10-phenanthrolin-3-yloxy)-1-(1,10-
phenanthrolin-8-yloxy)propan-2-yl)ethane-1,
2-diamine]Cl4
CuCl2 (17.0 mg, 0.1 mmol) was added as a solid to a
suspension of 1 (75.7 mg, 0.1 mmol) in DMF (25 mL).
J Biol Inorg Chem (2008) 13:575–586 577
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The reaction was stirred overnight at 50 C. DMF was
partially evaporated under reduced pressure, and the crude
compound was precipitated in 100 mL of diethyl ether. The
solid material was filtered off and washed with 3 9 20 mL
of diethyl ether, and dried overnight at 50 C under
reduced pressure to give 2 as a green powder (yield 93%).
X-band electron paramagnetic resonance (solid state):
g = 2.1191. UV–vis (H2O) kmax 282 (40,100), 321
(12,500), 333 (10,100), 347 (3,280) nm. High-resolution
MS (m/z): [2M–2Cl] calcd for (C58H52Cl6N12O4Pt2Cu2)
2+
853.00852, 853.5096, 854.0097, 854.5087, 855.0088,
855.5072, 856.0073, 856.5083, 857.0100, 857.5067; found
853.0117, 853.5117, 854.0114, 854.5110, 855.0107,
855.5105, 856.0103, 856.5101, 857.0098, 857.5097.
Cytotoxicity
The cytotoxicity of complexes 1 and 2 has been determined
for breast (MCF7), two glioblastoma (Hs683 and U373),
two colorectal (HCT-15 and LoVo) and lung (A549) cancer
cell lines (see supplementary material for experimental
details and results).
Solutions of complexes for experiments with DNA
One millimolar DMSO solutions of the complexes inves-
tigated were prepared, and were subsequently diluted with
Milli-Q water.
Nuclease activity on supercoiled DNA
One millimolar DMSO solutions of the complexes inves-
tigated were diluted to, respectively, 200, 400 and
1,000 nM with Milli-Q water. Five microliters of the
complex solution was added to 10 lL of supercoiled
UX174 DNA (Invitrogen, 7 nM, 40 lM base pairs) in
6 mM NaCl, 20 mM sodium phosphate buffer (pH 7.2),
and incubated for 20 h at 37 C. To initiate the cleavage,
5 lL of a 20 mM mercaptopropionic acid solution in water
was added, and the resulting reaction mixture was incu-
bated at 37 C for 1 h. The reaction was quenched at 4 C,
followed by the addition of 4 lL of loading buffer (glyc-
erol with bromophenol blue) prior to the loading on a
0.8% agarose gel containing 1 lg mL-1 ethidium bro-
mide. The gels were run at a constant voltage of 70 V
for 90 min in 2-amino-2-(hydroxymethyl)propane-1,3-diol
(Tris) borate edta (TBE) buffer containing 1 lg mL-1
ethidium bromide. The gels were visualized under a
UV transilluminator, and the bands were quantified using
a Bio-Rad Gel Doc 1000 apparatus interfaced with a
computer.
Time-course experiments of DNA cleavage
Fifty microliters of the complex solution was added to
100 lL of supercoiled UX174 DNA (Invitrogen, 7 nM,
40 lM base pairs) in 6 mM NaCl, 20 mM sodium phos-
phate buffer (pH 7.2), and the resulting reaction mixture
was incubated for 20 h at 37 C. To initiate the cleavage,
50 lL of 20 mM mercaptopropionic acid was added, and a
sample was taken out every 10 min. Four microliters of
loading buffer (glycerol with bromophenol blue) was
added, and the sample was directly frozen in liquid nitro-
gen. When all samples had been collected, they were
loaded on a 0.8% agarose gel containing 1 lg mL-1 ethi-
dium bromide.
Analyses with 50-32P-end-labeled DNA
Oligonucleotides (ODNs) I and II and the primer (Fig. 2)
were purchased from Eurogentec, and purified on a 15%
polyacrylamide (acrylamide to bisacrylamide ratio 19:1)
gel. The denaturating gel contained 7 M urea. The migra-
tions was performed in the presence of TBE buffer at
2,500 V for 3 h. The concentrations of single-stranded
ODNs were determined by UV titration at 260 nm [25].
The ODNs were end-labeled with 32P using standard pro-
cedures with T4 polynucleotide kinase (New England
BioLabs) and [c-32P]ATP for the 50-end, before being
purified on a MicroSpin G25 column (Pharmacia) [26].
Comparison of the platinum–ODN adducts formed
with the different complexes
50-end-labeled ODN I (2 lM) was annealed to 1 equiv of
its complementary strand ODN II in 1,100 lL of Tris–
HCl (20 mM, pH 7.2) by heating to 90 C for 5 min,
followed by slow cooling to room temperature. Then,
60 lL of this solution was incubated with 60 lL of the
complex solution (6 or 20 lM) for 20 h at 37 C, fol-
lowed by precipitation with 100 lL of sodium acetate
buffer (3 M, pH 5.2) and 1,300 lL of cold ethanol. Pel-
lets were rinsed with ethanol and lyophilized. Samples
were dissolved in formamide containing bromophenol
blue and xylene cyanol and heated for 3 min at 90 C
before being loaded on the gel. Platinum–DNA adducts
were analyzed by denaturing 20% polyacrylamide gel
electrophoresis, then by phosphorimagery.
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Comparison of the sequence-selective binding
by primer extension experiments with Taq polymerase
ODN I (2 lM) was annealed to ODN II (2 lM) in
1,100 lL of Tris–HCl (20 mM, pH 7.2) by heating to
90 C for 5 min, followed by slow cooling to room tem-
perature. Sixty microliters of this solution was then
incubated with 60 lL of the complex solution (6 or 20 lM)
for 20 h at 37 C, followed by precipitation with 100 lL of
sodium acetate buffer (3 M, pH 5.2) and 1,300 lL of cold
ethanol. Pellets were rinsed with ethanol and lyophilized.
For primer extension, an aliquot of the redissolved samples
(0.25 lM) was annealed with 50-end-labeled primer
(0.25 lM) and 1 equiv of ODN I (0.25 lM) in the enzyme
buffer (the buffer contains a small amount of reductant, but
not enough to induce DNA cleavage by complex 2) before
the addition of 250 lM dGTP, dCTP, dATP and dTTP and
2.5 U of Taq polymerase (final concentrations are given,
the total volume was 10 lL). One equivalent of unmodified
ODN I was added in order to displace the ODN II from the
duplex and replace it with the labeled primer. The samples
were reacted at 37 C for 30 min, and 1 lL of edta (0.2 M)
was subsequently added. Samples were dissolved in
formamide containing bromophenol blue and xylene cya-
nol and heated for 3 min at 90 C, before being loaded on
the gel. Five microliters of sample was then analyzed by
denaturing 20% polyacrylamide gel electrophoresis and
phosphorimagery. The Maxam and Gilbert [27] sequencing
scale, including a final scale of T4 polynucleotide kinase
digestion to remove 30-end phosphates, was used to analyze
the DNA fragments. The sequencing experiments show, in
addition to a strong, easily assigned G signal, also a weak
A signal.
Comparison of the cleavage patterns of ODN I–ODN II
induced by the copper complexes
The 50-end-labeled 36mer target (2 lM) was annealed to 1
equiv of its complementary strand in 1,100 lL of Tris–
HCl (20 mM, pH 7.2) by heating to 90 C for 5 min,
followed by slow cooling to room temperature. To 60 lL
of this solution was added 60 lL of complex 1, 2 or 3
solutions (20 lM). Some of the samples involving com-
plex 2 were incubated for 19 h, followed by the addition of
1 equiv of CuCl2 per complex and subsequent incubation
(1 h). The other samples were incubated for 20 h at 37 C.
Next, all samples were precipitated with 100 lL of sodium
acetate buffer (3 M, pH 5.2) and 1,300 lL of cold ethanol.
Pellets were rinsed with ethanol and lyophilized, then
dissolved to 1.33 lM in Tris–HCl buffer (13.3 mM, pH
7.4). For the cleavage experiments, to 15 lL of this
solution was added 5 lL of a 0.8 mM ascorbate solution
(5 lL of water was added to the controls). The samples
were incubated at 37 C for 1 h, followed by precipitation
in 20 lL of sodium acetate buffer (3 M, pH 5.2) con-
taining 1 lg of salmon testes DNA and 180 lL of cold
ethanol. Pellets were rinsed with ethanol and lyophilized.
In order to study the DNA cleavage mechanism, additional
treatments were performed on some samples: (1) heating
at 90 C in 50 lL of 4-(2-hydroxyethyl)-1-piperazinee-
thanesulfonic acid (HEPES)–NaOH buffer (0.1 M, pH 8.0)
for 30 min, followed by ethanol precipitation; (2) heating
at 90 C in 50 lL of piperidine (0.2 M in water) for
30 min, followed by lyophilization. Samples were dis-
solved in formamide containing bromophenol blue and
xylene cyanol and heated for 3 min at 90 C, before being
loaded on the gel. Samples were analyzed by denaturing
20% polyacrylamide gel electrophoresis, then phospho-
rimagery. The Maxam and Gilbert [27] sequencing scale
was used to analyze DNA fragments. The sequencing
experiments show, in addition to a strong, easily assigned
G signal, also a weak A signal.
Results and discussion
Design and synthesis of a heterodinuclear
platinum–copper complex
A ditopic ligand 7 was designed to favor the simultaneous
coordination of a platinum and a copper entity; hence, the
resulting bifunctional complex would combine the ability
to form a kinetically inert coordination bond with DNA,
thanks to its cis-Pt moiety, with the cleavage properties of
Cu(3-Clip-Phen). Two coordination compounds, namely,
the platinum complex 1 and the heterodinuclear platinum–
copper complex 2 (Fig. 1) were prepared with the ligand
7. The binding ability of the platinum unit and the cleavage
selectivity of the Cu(3-Clip-Phen) moiety were inves-
tigated. The results were compared with those for the
known Cu(3-Clip-Phen) complex (3). The short separation
between the Pt and the Cu centers in complex 2 most likely
affects the preference for platinum to bind in the major
groove, and in the minor groove for copper. Accordingly,
the coordination of the platinum moiety in the major
groove will force the Cu(3-Clip-Phen) component to bind
in the major groove, and vice versa.
The general synthetic pathway to prepare complexes 1
and 2 is depicted in Scheme 1. The selective and com-
plete platination of the ethylenediamine unit using 1 equiv
of K2PtCl4 was monitored by
195Pt NMR and 1H NMR.
The in situ reaction of the resulting platinum derivative 1
with 1 equiv of CuCl2 produces the heterobimetallic
complex 2.
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Cleavage of supercoiled DNA
The relaxation of supercoiled circular UX174 DNA (form
I) into its relaxed (form II) and linear (form III) confor-
mations was monitored to compare the aerobic cleavage
abilities of complexes 2 and 3, in the presence of a
reducing agent (Fig. 3). First, the complexes were incu-
bated for 20 h, to allow the formation of platinum–DNA
adducts. The nuclease activity was subsequently initiated
by the addition of 5 mM mercaptopropionic acid. Complex
2 exhibits a markedly higher nuclease activity than
Cu(3-Clip-Phen) (3) (compare lanes 5 and 9 in Fig. 3).
Indeed, at complex concentrations of 100 nM, most
supercoiled DNA has reacted to form circular and linear
DNA in the case of 2, while Cu(3-Clip-Phen) only gener-
ates a small amount of form II (Fig. 3, lanes 4 and 8).
Moreover, almost all the DNA has reacted to form smaller
DNA fragments (migrating as a smear) at a complex
concentration of 250 nM for 2 (Fig. 3, lane 5), whereas
no smear is observed for Cu(3-Clip-Phen) (Fig. 3, lane 9).
Interestingly, at a concentration of 100 nM for complex 2,
form III is detected before the total disappearance of form I
(Fig. 3, lane 4) [19]. This result indicates that the hetero-
dinuclear platinum–copper complex is able to perform
direct double-strand cuts since form I is still detected in the
reaction. Such double-strand breaks are highly cytotoxic,
since the cells have difficulties to repair such damage [28,
29]. Cu(3-Clip-Phen) is only able to perform repetitive
single-strand cuts [15]. Interestingly, the cleavage activity
of complex 2 is also more efficient compared with that of
the platinum–copper complexes previously reported by our
group [19].
Time-course studies of DNA cleavage by complexes 2
and 3 were carried out to further investigate the direct
double-strand cleavage event (Fig. 4). Complex 3 at a
concentration of 250 nM generates a maximum of 80% of
circular DNA (form II) after a reaction time of about 1 h
[19]. Around 20% of linear DNA (form III) is produced via
the action of 3 after 70 min. Remarkably, the formation of
form III is only observed after a reaction time of 30 min
when already 60% of form II has been produced. For a
150 nM solution of complex 2, linear DNA (form III) is
generated from the initial stages of the cleavage reaction,
with supercoiled DNA (form I) still being present (Fig. 4).
Also, only a maximum of 60% of form II is generated.
These features reflect the ability of 2 to perform direct
double-strand breaks, most likely as a result of the binding
of the platinum moiety to DNA, allowing the copper part to
achieve more than one oxidative cleavage in the close
proximity of the platinum coordination site.
Analysis of the platinum adducts on ODN I
of the ODN I–ODN II duplex target
High-resolution analyses with a 36-bp DNA duplex
(ODN I–ODN II) were performed to investigate the
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Scheme 1 Preparation of complexes 1 and 2. Reagents and condi-
tions as follows: i dimethylformamide (DMF), diisopropylethylamine,
100 C, 2 days; ii ethanol, H2N–NH2, reflux, overnight; iii K2PtCl4,
MeOH/water, room temperature, 6 h; iv CuCl2, DMF, 50 C,
overnight
Fig. 3 Comparative experiments of the oxidative cleavage of UX174
plasmid DNA performed by 2 and 3. Lane 1 control DNA. Lane 2
250 nM solution of 2. Lane 3 50 nM 2, in the presence of 5 mM
mercaptopropionic acid (MPA). Lane 4 100 nM 2, in the presence of
5 mM MPA. Lane 5 250 nM 2, in the presence of 5 mM MPA. Lane
6 250 nM 3. Lane 7 50 nM 3, in the presence of 5 mM MPA. Lane 8
100 nM 3, in the presence of 5 mM MPA. Lane 9 250 nM 3, in the
presence of 5 mM MPA
Fig. 4 Time-course experiments of DNA cleavage (20 lM in base
pairs) over a period of 70 min. Complex 2 (150 nM) was incubated
for 24 h, followed by activation with 5 mM MPA and air
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coordination of the platinum component of the bifunctional
complexes to DNA, (Fig. 5a). The sequence of this duplex
was chosen to include GG and AG sites (which are the two
major binding sites of cis-Pt(II) complexes) on one strand
(ODN I). The results obtained after incubation of the
complexes with the duplex labeled on the 50-end of ODN I
for 24 h were analyzed by polyacrylamide gel electro-
phoresis under denaturing conditions and are shown in
Fig. 5a. Denaturing conditions allowed the analysis of the
Pt–DNA adducts on ODN I of the duplex.
Molecules able to irreversibly bind to DNA will retard
the rate of migration of the modified ODN, compared with
that of the free ODN; therefore, ODN–Pt adducts appear as
retarded bands on gels. The incubation with 3 equiv of
cisplatin clearly reveals an impeded mobility of the ensuing
cisplatin–ODN I adduct (Fig. 5a, lane 2). Only traces of
free ODN I were detected; 89% of the ODN I had been
modified. The incubation of the DNA duplex with 10 equiv
of cisplatin results in a total conversion of ODN I (Fig. 5a,
lane 3). Complex 1 shows the formation of Pt–ODN I
adducts (Fig. 5a, lanes 4 and 5). Two distinct bands are
clearly observed when 10 equiv of complex 1 is incubated
with the DNA target, indicating the formation of Pt–ODN I
adducts. The quantification of free ODN I reveals that as
much as 84% of this DNA fragment has reacted. The use of
complex 2 leads to comparable results, with the conversion
of 88% of the initial ODN I (Fig. 5a, lane 7). However, the
reaction between ODN I and complex 2 produces a smear
(i.e., a range of products) on the gel. Our previously
reported compounds showed reduced formation of Pt–
ODN adducts under similar experimental conditions com-
pared with complexes 1 and 2 [19].
Sequence selective binding of complexes
1 and 2 compared with cisplatin
Primer extension experiments were performed to investi-
gate the sequence-selective binding of the platinum units to
the ODN I fragment of the ODN I–ODN II DNA duplex
(Figs. 5b, c, S1, S2). The platinum complexes that did not
react with DNA were removed prior to the start of the
primer extension experiments. Nevertheless, it is possible
to have more than one platinum moiety coordinating the
ODN strand, since the concentrations of cisplatin, complex
1 and complex 2 were, respectively 3 and 10 times higher
than the concentration of the ODN I–ODN II DNA duplex.
Taq polymerase has proven to be a valuable tool for the
determination of the sequence selectivity of various plati-
num complexes [23, 30–39]. Cisplatin inhibits the
enzymatic polymerization at the anticipated GG and AG
sites (Fig. 5b, c), but the majority of cisplatin is detected at
the GG site. It should be noted that once the ODN I strand
contains two Pt adducts on both the GG and AG site, the
enzyme stops only at the GG site. Therefore, it is possible
that the amount of modified AG sites is underestimated.
Nevertheless, not all of the ODN I has been modified by the
complexes (Fig. 5a). It is therefore reasonable to say that
the majority of the ODN I contains only one Pt adduct and
that the AG site is indeed the minor site of interaction. The
stop sites observed for complex 1 are also located for a
major part at the GG base pairs and for a minor part at the
AG base pairs. Complex 2 shows only stops at the GG
binding site. These results indicate that the platinum moi-
ety interacts with its preferential binding site. The
difference between cisplatin and complexes 1 and 2 is
the precise point at which the peak intensity occurs at the
damaged site. The stops of the Taq polymerase are mainly
located at the A base before the GG site for cisplatin,
complex 1 and complex 2. However, the enzyme stops
induced at the GG site are more equally distributed among
the GAC site in the cases of complexes 1 and 2 (Fig. 5b, c;
the size of the arrows is an indication of the damage
intensity). The binding of complexes 1 and 2 apparently
Fig. 5 a Polyacrylamide gel electrophoresis (PAGE) analysis of the
Pt–ODN I adducts of the ODN I–ODN II duplex target (1 lM). ODN
I was 50-end-labeled with 32P-phosphate. The complexes were
incubated with the DNA for 24 h before analyses. Lane 1 ODN I.
Lane 2 3 lM cisplatin. Lane 3 10 lM cisplatin. Lane 4 3 lM 1. Lane
5 10 lM 1. Lane 6 3 lM 2. Lane 7 10 lM 2. b Phosphorimager data
of a DNA sequencing gel comparing the sequence specificity of
cisplatin, 1 and 2. All the samples were extended using Taq
polymerase, starting from the 50-end-labeled primer. Lane 1 blank
experiment; Lane 2 3 lM cisplatin; Lane 3 10 lM 1. Lane 4 10 lM 2.
It is noteworthy that the GTA and GGAC sites give the sequence of
the opposite strand that induced the stopping of the primer extension
(Figs. S1, S2). c Nucleobase sequence of ODN I, and indication of the
damage sites induced by cisplatin, 1 and 2. Large arrows and small
arrows represent, respectively, major and minor stop sites
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produces bulky adducts, thus allowing a partial stop at the
second nucleotide before the classic position, at the GG
adduct, since an increase of the reaction time with the
enzyme (from 30 to 120 min, Fig. S3; complex 1) induces
a bypass of the stop at the C base (associated with a
decrease of the peak intensity when compared with that for
G). The difference between cisplatin and complex 1 is
more pronounced at the AG site. Although it is the minor
binding site, the damage induced by cisplatin almost
exclusively takes place at the G base, at the 50-end of ODN
I. The Taq polymerase stops for complex 1 are mainly
observed at the A base.
Cleavage of the ODN I strand of the ODN I–ODN II
duplex
The cleavage of the ODN I–ODN II duplex with com-
plexes 1–3 was investigated by polyacrylamide gel
electrophoresis, the target being labeled on the 50-end of
ODN I (Fig. 6). To the best of our knowledge, studies of
such bifunctional complexes have been reported only twice
[40, 41].
Complexes 1 and 2 were preincubated for 20 h to allow
the coordination of the platinum moiety to the DNA target.
For complex 1, the preincubation was subsequently
followed by the coordination of 1 equiv of copper, since
the copper-free complex does not show any nuclease
activity. The noncoordinated complexes were removed
by precipitation before the cleavage was initiated by the
addition of ascorbic acid (0.2 mM) under aerobic conditions.
Additional treatments (HEPES pH 8.0 and piperidine) were
carried out.
The noncovalent interaction of Cu(3-Clip-Phen) (3) with
DNA permits its abstraction from the ODNs by a simple
precipitation step. A tenfold excess of 3 (compared with
the ODNs) does not generate cleavage products after the
precipitation step (Fig. 6, lane 24), while 1 equiv of 3
without precipitation exhibits significant cleavage (Fig. 6,
lane 20). The platinum-containing complexes 1 and 2 form
kinetically inert bonds with DNA, and therefore cannot be
removed from the ODN during the precipitation step. In
contrast, the unreacted complexes are eliminated.
As expected, the cleavage pattern of 3 is nonspecific,
[18] as about 20% of the target is oxidized at all nucleo-
tides (Fig. 6, lane 20). The cleavage achieved by complex
2 in the presence of ascorbic acid results in the full and
partial disappearance of, respectively, the Pt–ODN I
adducts and the ODN I band (Fig. 6, lane 10). The total
cleavage amounts to nearly 80%, and its pattern is different
from the features resulting from the action of 3, but no
clear sequence selectivity is observed. Accordingly, a
Fig. 6 a PAGE analysis of cleavage of ODN I of the ODN I–ODN II
duplex (1 lM) by compounds 1–3 (10 lM when unspecified). The
cleavage reactions were initiated with ascorbate (200 lM) in aerobic
conditions or by heating for 30 min at 90 C in aqueous 0.2 M
piperidine. The Maxam–Gilbert sequencing reactions A + G (lane 1)
and G (lane 2) were performed to determine the cleavage sites. On the
top of the gel are indicated the conditions used during the experiments
(details are given in ‘‘Materials and methods’’). Lanes 3–6 are for
controls without complexes. Lanes 17–22 are for experiments that
were performed in the presence of 1 lM 3. b High-contrast picture of
lanes 8, 10, 11, 13, 15 and 16 in a allowing easier observation of the
the cleavage pattern. DpH 8 was a heating step of 30 min at 90 C in
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)–NaOH
buffer (0.1 M, pH 8.0). Unlinked complexes 1 and 2 were removed in
a precipitation step with ethanol before the induction of cleavage
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smear of products is noted in contrast to 3, suggesting that
the mechanism of the cleavage is different. This observa-
tion may be explained by either of the following
possibilities: (1) some cuts are due to platinum adducts of
complex 2 positioned on the other strand of the duplex
(ODN II); (2) the extensive cleavage observed most likely
indicates that the ODN I fragment experiences more than
one cut; therefore, complex 2 should have been released
after repetitive cuts from ODN I and should be able to cut
the free ODN.
To verify this hypothesis, the experimental conditions
were adjusted to introduce fewer platinum adducts onto the
target (20% against the 80% of modification of ODN I
shown in Fig. 6), and less ascorbate (100 lM) was used to
limit the recleavage events. However, the resulting cleav-
age pattern appears to be similar to that observed with the
former conditions (Fig. 8).
One equivalent of CuCl2 was added to complex 1, after
the formation of Pt–DNA adducts, to analyze the cleavage
selectivity of the resulting compound. A comparatively less
efficient cleavage was achieved using complex 1 with extra
added CuCl2, when compared with complex 2 (compare
lanes 10 and 15 in Fig. 6), possibly as a result of the partial
coordination of the copper ions to 1. Similarly to 2, the
cleavage pattern obtained with 1 is found to be significantly
different from that of 3 (Fig. 6, lane 20). Interestingly, the
free ODN I is not affected during the cleavage process, as
only the ODN fragments containing platinum adducts are
cleaved. Furthermore, a sequence-selective cleavage (asso-
ciated with the formation of fragments of ODN I including
probably the 30-phosphate end, since they comigrated as
Maxam and Gilbert sequencing fragments) is observed in
the close vicinity of the GG and AG sites (indicated as black
bars in Fig. 6, left). The intensity of the bands is much
stronger at the GG site, reflecting the results of the primer
extension experiments previously obtained. The four base
pairs neighboring the GG site in the 50-direction are also
affected by the cleavage of complex 1. In the 30-direction, no
clear bands are observed, but a smear is observed, which can
be explained as follows: the cleavage products remain
coordinated to the complex and have therefore a totally
different mobility, compared with the Maxam–Gilbert
sequencing fragments. The apparent smear observed in the
30-direction supports this assumption, since such behavior is
observed for Pt–ODN I adducts including the copper com-
plex (Fig. 5a, lane 6), and can therefore be expected for
cleavage fragments that coordinate to the complex.
A heating step in HEPES buffer (90 C; pH 8.0) is often
used to cleave the metastable products resulting from the
oxidation of deoxyribose. This treatment of the cleavage
products obtained with complexes 1–3 did not show a
strong increase of the DNA cuts (Fig. 6, respective com-
parisons between lanes 15, 16 and 10 and 11, 20 and 22).
Therefore, products of strand cleavage are essentially
observed during this analysis. However, the smears
observed in lanes 10 and 15 are partially converted into
bands, indicating that some cleavage products, arising from
the oxidation of deoxyribose, are sensitive to alkaline
conditions.
More drastic alkaline heating (as with piperidine) allows
one to detect the oxidations of the nucleobases that do not
induce direct DNA cleavage [6]. Surprisingly when this
treatment is applied to complexes 1 (with addition of
1 equiv of copper) and 2, clear cleavages are observed,
although the systems had not been incubated with ascorbate
(Fig. 6, lanes 13 and 8, respectively). This phenomenon is
dependent of the presence of copper ion, since it is not
observed for Pt–ODN I adducts with complex 1 without the
addition of CuCl2 (results not shown). Therefore, these
alkaline conditions are sufficient to induce a redox activity
of the copper complex part of the hybrid molecule [this
phenomenon has not been observed with Cu(3-Clip-Phen),
which can be removed during a precipitation step preceding
the heating in the presence of piperidine]. Interestingly,
only the Pt–ODN I adducts are cleaved; none of the free
ODN I is degraded and selective cleavages are observed
around the position of adducts detected during primer
extension experiments. Unfortunately, this activity of the
copper complexes covalently linked to the target does not
allow us to analyze whether or not the dual Pt–Cu com-
plexes perform the oxidation of nucleobases.
Cleavage of the ODN II strand of the ODN I–ODN II
duplex
The same experiments were performed with the ODNI–
ODNII duplex labeled on the 50-end of ODN II (Fig. 7).
Similar amounts of Pt–ODN II adducts are formed with
complexes 1 (Fig. 7, lane 8) and 2 (Fig. 7, lane 3). Most
likely, only parts of the platinum components of complexes
1 and 2 are bound on ODN II at the preferential AG site,
and the cleavages do not seem to be restricted to one
selective site. Other adducts are probably also present. The
occurrence of platinum–guanine monoadducts on ODN II
(which is particularly rich in guanine bases) may explain
the results observed. Further investigations are required to
confirm these proposals.
Both complex 1 with added copper and complex 2 show
extensive cleavage activities in the presence of ascorbic
acid in air (Fig. 7, lanes 11 and 6, respectively). In the
experiments with complex 2, the Pt–ODN II adducts have
fully reacted, while the free ODN II is only partly altered.
The cleavage fragments are poorly resolved on the gel
(a smear is essentially observed), and treatment with
HEPES or piperidine fails to improve their analysis. These
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cleavage fragments are composed of modified DNA. It can
be reasonably proposed that the fragments include Pt–ODN
II adducts and that these adducts produce a smear during
the migration in polyacrylamide gel electrophoresis. All
these results indicate that the platinum moieties of com-
plexes 1 and 2 bind, as expected, to the preferential
platinum site on ODN II, but also and mainly to single A
and G nucleobases.
Comparison between the cleavage of duplex
and single-stranded DNA
A comparison between the cleavage patterns resulting from
the action of complex 2 on single-stranded ODN I and on the
duplex ODN I–ODN II was made to appraise the influence of
the formation of Pt–ODN II adducts on the resulting cleavage
(Fig. 8). Pt–ODN I adducts are formed when the single
strand is used, and these adducts are essentially positioned at
the GG site of ODN I (the results of the primer extension are
not shown). For this study, only 20% of the platinum adducts
on ODN I of the duplex and 40% of the platinum adducts on
the single strand were created in order to have a maximum of
one adduct per DNA target, and thus to simplify the analysis.
The cleavage was induced by the addition of a small quantity
of ascorbate (100 lM) to disfavor recleavage events.
The cleavage of the ODN I fragment of the duplex
results in a cleavage pattern exhibiting various moderate
peaks in the 30-region of the GG base pair of ODN I. The
cleavage of single-stranded ODN I by complex 2 gives rise
to a smear in the same region. The smears observed
characterize cleaved ODN I products that are still coordi-
nated to complex 2. Accordingly, the weak peaks in this
region of the DNA sequence are most likely due to the
cleavage of complex 2–ODN II adducts on both strands.
Since the conditions used favor a maximum of one Pt–
ODN adduct per duplex, these cleavages on nonmodified
ODN I probably originate from complex 2–ODN II
adducts.
Fig. 7 PAGE analysis of cleavage of ODN II of the ODN I–ODN II
duplex (1 lM) by compounds 1–3. The cleavage reactions were
initiated with ascorbate (200 lM) in aerobic conditions or by heating
for 30 min at 90 C in aqueous 0.2 M piperidine. The Maxam–Gilbert
sequencing reactions A + G (lane 1) and G (lane 2) were performed
to determine the cleavage sites. On top of the gel are indicated the
conditions used during the experiments (details are given in
‘‘Materials and methods’’). DpH 8 was a heating step of 30 min at
90 C in HEPES–NaOH buffer (0.1 M, pH 8.0). Unlinked complexes
1 and 2 were removed in a precipitation step with ethanol before the
induction of cleavage
Fig. 8 Phosphorimager scanning of the PAGE-cleavage patterns of
ODN I by complex 2. The cleavage was performed on either the ODN
I–ODN II duplex (50-end-labeled on ODN I) or on single-stranded
ODN I. Cleavage was induced by the addition of ascorbate (100 lM)
after the removal of the unlinked complex during a precipitation step
with ethanol. The clear band area on the 30-side of the GG site of the
duplex is probably due to a covalent adduct of complex 2 on ODN II
(the complementary strand of the duplex). 30-Phosphoglycolate
cleavage fragments are labeled with an asterisk. The other clear bands
were attributed to fragments of ODN I including 30-phosphate ends
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The results are summarized in Fig. 9. Importantly, the
cleavage of ODN I by Pt–ODN II adducts appears to be
partially responsible of the visible nonselective cleavage of
the duplex by complex 2.
Interestingly, the weak peaks observed on the 50-side of
the cleavage fragments (and shown with an asterisk in
Fig. 8) probably correspond to DNA fragments with 30-
phosphoglycolate extremities. Indeed, these species are
observed at the position of the cleavage products of the
duplex produced by the action of complex 3, and which
have been previously characterized [15]. Such fragments
were earlier identified as the result of the oxidation of the
C40 position of 2-deoxyribose. Further investigations are
required to confirm these proposals.
Concluding remarks
The novel heterodinuclear platinum–copper complex 2
exhibits improved nuclease activity, compared with its
parent compound Cu(3-Clip-Phen) (3), and is able to per-
form double-strand breaks. The platinum moiety acts as an
anchor to DNA, forcing the Cu(3-Clip-Phen) group to
generate cuts in close proximity to the Pt–DNA adducts,
hence even allowing direct double-strand breaks. Mecha-
nistic investigations on a 36-bp DNA fragment (ODN I–
ODN II) revealed that platinum adducts are indeed formed
with both complexes 1 and 2. The platinum moiety of
complexes 1 and 2 binds to GG (primarily) and AG sites,
like cisplatin. Nevertheless, the Taq polymerase enzyme
stops at different base pairs for cisplatin and complexes 1
and 2. This feature suggests that complexes 1 and 2 induce
different distortions (compared with cisplatin) upon their
binding to DNA, most likely owing to the bulkiness of
the 3-Clip-Phen moiety. Complex 1 with added copper
(1 equiv) shows a sequence-selective cleavage, in the close
proximity of the platinum adducts. A sequence-selective
cleavage is also observed for complex 2, but to a lesser
extent compared with complex 1. The opposite strand also
contains Pt–DNA adducts, but no clear sequence selectivity
is observed, most likely owing to the lack of preferential
platinum binding sites. These atypical platinum adducts
lead to the partial damage of the other DNA strand, as is
clearly evidenced by comparison of the cleavage products
on a single-stranded or duplex DNA.
Interestingly, it has been found that piperidine is also
able to activate the Cu(3-Clip-Phen) component of the
bifunctional platinum–copper complexes, a feature so far
not reported. Thus, a good sequence-selective cleavage is
observed upon treatment of complex 1 with piperidine.
Reasonable sequence selectivity is achieved with complex
2. The investigation of the mechanism of cleavage by
complex 2 is currently in progress.
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